IN THIS MONTH'S ISSUE:
May 2016

Flibanserin (Addyi): Data and Opinion
Further research is required to determine whether the modest benefits from flibanserin (Addyi) for women with acquired generalized hypoactive sexual desire disorder outweigh its risks.

Varenicline in Schizophrenia
A recent study of varenicline (Chantix) in patients with schizophrenia found that, compared with placebo, it reduced smoking without increasing psychiatric symptoms and was well tolerated but did not improve cognition.

New Treatment Approaches for Bipolar Depression
Recent studies of treatments for bipolar depression report that lamotrigine (Lamictal and others) added to quetiapine (Seroquel and others) improves depressive symptoms; folic acid may reduce the effectiveness of lamotrigine; and agomelatine is not efficacious in this population.

In Brief
Primary Care Physicians Use Management Care Processes Less for Depression than for Other Chronic Illnesses: Antipsychotic-Treated Patients with Schizophrenia Experience No Benefits from Adjunctive Oxytocin

Register for FREE Online Access

Please fill in the information requested below to start your free online subscription! All fields marked with a red asterisk (*) are required.

Your Contact Information


If you do not live in the United States or Canada, please select "none" for state.
  
Login Information

(Your email address is your user name)
Residency Director Information
(For resident status verification)
  
Residency Information
 
* denotes required fields.